Cryptotanshinone increases the sensitivity of liver cancer to sorafenib by inhibiting the STAT3/Snail/epithelial mesenchymal transition pathway

Zhiyu Li; Kegong Chen; Chao Cui; Yinghui Wang; Dequan Wu

doi:10.2478/fzm-2022-0016

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Cryptotanshinone increases the sensitivity of liver cancer to sorafenib by inhibiting the STAT3/Snail/epithelial mesenchymal transition pathway

DOI: 10.2478/fzm-2022-0016

Cryptotanshinone increases the sensitivity of liver cancer to sorafenib by inhibiting the STAT3/Snail/epithelial mesenchymal transition pathway

Zhiyu Li

Kegong Chen

Chao Cui

Yinghui Wang

Dequan Wu

Keywords：cryptotanshinonesorafenibsorafenib-resistanceSTAT3 signalingliver cancer

Publication Date：2022-04-30

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：10( 119-128 )

Frigid Zone Medicine

Year, Vol.(Issue)：2022,2(2)